Clinical trial
Metformin in Non-Alcoholic Fatty Liver Disease
NCT00303537 · University Hospital, Aker, Other · Unknown status
Key facts
| NCT number | NCT00303537 |
|---|---|
| Title | Metformin in Non-Alcoholic Fatty Liver Disease |
| Official title | Double Blind, Randomized, Placebo Controlled Trial With Metformin in Non-Alcoholic Fatty Liver Disease (NAFLD) |
| Lead sponsor | University Hospital, Aker, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Fatty Liver |
| Intervention type | Drug |
| Interventions | metformin |
| Enrollment | 90 |
| Start date | Nov 1, 2004 |
| Completion | Jun 1, 2008 |
| First posted | Mar 17, 2006 |
| Last update posted | Jul 2, 2007 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: